Expert.ai S.p.a. · MIL:EXAI
Expert.ai — Expert System — Investor Day (April 2020)
12 slides from Expert.ai's investor day presentation, April 2020
Slide 1: Full Year Report 2019
FULL YEAR REPORT 2019 IR Top Smart Investor Day
Slide 2: Business Highlights
BUSINESS HIGHLIGHTS Rabobank Extends the Scope and For the Fourth Year in a Scale of Unstructured Data Row, AXA XL Leads Management by Leveraging Advisen’s Pacesetter Expert System’s Artificial Index Intelligence “Artificial Intelligence is a key pillar of our digitalization The list of AXA XL innov
Slide 3: Partnerships Development
PARTNERSHIPS DEVELOPMENT First results: revenues through partnerships have reached €3M (about 10% of the total). ES Business Partners: Main deals from Channel: • Multiyear Defense programs • Global System Integrators in 2 important EU Countries • Global Consulting firms • Automation project on EU pr
Slide 4: Financial & Management Highlights
FINANCIAL & MANAGEMENT HIGHLIGHTS On April 23, 2019 a capital increase of €7m has been subscribed by a pool of private investors: entrepreneurs, managers and professionals including Claudio Costamagna, Diego Piacentini and Francesco Caio. “As a group of financial investors, we are firmly convinced o
Slide 5: Market Validation
MARKET VALIDATION Expert System has been included in “Now Tech: AI-Based Text Analytics Platforms, Q1 2020”, a report by Forrester Research, Inc. The report is designed to empower business insight professionals working on text analytics initiatives to understand the value they can expect from an AI-
Slide 6: 2019 at Glance
2019 AT GLANCE 2019 in line with expectations: Revenues* amount to €31.6M, compared to €28.7M in 2018 (+10.1%), close to our strategic guidelines (€33M, -4%). EBITDA at €5.5M (€4.6M in 2018), in line with our strategic guidelines (€5M – €6M). Recurring licences on total licences sold have reac
Slide 7: Revenues by Region 2019
REVENUES BY REGION 2019 54% of sales are abroad, 30% in Europe and 24% in USA Good YoY results in Italy, UK, and Germany. Excellent YoY results from reorganization of business in France (sales +41%). Investment in 2H2019 in US sales and support teams to support accelerated growth in key verticals of
Slide 8: Revenues by Type 2019
REVENUES BY TYPE 2019 Licences: the vast majority of new customers opted for a recurring license. 76% of new licenses sold in 2019 were recurring. These results confirm our efforts in implementing a new business model based on recurring contracts. We aim to a total switch to recurring licenses and r
Slide 9: From EBITDA to Net Results 2018 vs 2019
FROM EBITDA TO NET RESULTS 2018 VS 2019 Amortization -€0.5M Amortization is mainly related to R&D costs (€5.1M) and to the consolidation difference Year ended 31 December - €/m 2018 2019 Δ resulting from the acquisitions (€2.2M, 2019 is the last year of amortization). EBITDA 4,6 5,5 0,8 Amortization
Slide 10: COVID Response
COVID RESPONSE Expert System Clinical Research Navigator (CRN) provides access, insight, and organization of critical information from 100MM medical research and clinical trial documents. Offering CRN free for three months to accredited research and medical facilities to provide immediate access
Slide 11: Strategic Guidelines
STRATEGIC GUIDELINES Invest in marketing, sales and customer success efforts for US corporate market focused on Insurance, Finance, and Information/Publishing/Media. Accelerate expansion of reach through partner channel, including select Global Solutions Integrators and local vertically and AI/R
Slide 12: Thanks
THANKS linkedin.com/company/expert-system twitter.com/Expert_System marketing@expertsystem.com 12